{"id":"https://openalex.org/W2561828715","doi":"https://doi.org/10.1182/blood.v108.11.2104.2104","title":"Membrane-Stable, Humanized CD154 Gene Therapy for Patients with CLL.","display_name":"Membrane-Stable, Humanized CD154 Gene Therapy for Patients with CLL.","publication_year":2006,"publication_date":"2006-11-01","ids":{"openalex":"https://openalex.org/W2561828715","doi":"https://doi.org/10.1182/blood.v108.11.2104.2104","mag":"2561828715"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v108.11.2104.2104","doi":"https://doi.org/10.1182/blood.v108.11.2104.2104","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v108.11.2104.2104","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089428686","display_name":"William G. Wierda","orcid":"https://orcid.org/0000-0002-7357-270X","observed_orcids":["https://orcid.org/0000-0002-7357-270X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William G. Wierda","raw_affiliation_strings":["CLL Research Consortium, San Diego, CA, USA","Leukemia, UT/MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CLL Research Consortium, San Diego, CA, USA","institution_ids":[]},{"raw_affiliation_string":"Leukemia, UT/MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006104041","display_name":"Susan Mary O'Brien","orcid":"https://orcid.org/0000-0002-2481-7504","observed_orcids":["https://orcid.org/0000-0002-2481-7504"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan M. O\u2019Brien","raw_affiliation_strings":["CLL Research Consortium, San Diego, CA, USA","Leukemia, UT/MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CLL Research Consortium, San Diego, CA, USA","institution_ids":[]},{"raw_affiliation_string":"Leukemia, UT/MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112234350","display_name":"Robier A. Aguillon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"R.A. Aguillon","raw_affiliation_strings":["Heme/Onc, UC, San Diego, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Heme/Onc, UC, San Diego, San Diego, CA, USA","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013814515","display_name":"Januario E. Castro","orcid":"https://orcid.org/0000-0003-2785-0892","observed_orcids":["https://orcid.org/0000-0003-2785-0892"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Januario Castro","raw_affiliation_strings":["CLL Research Consortium, San Diego, CA, USA","Heme/Onc, UC, San Diego, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CLL Research Consortium, San Diego, CA, USA","institution_ids":[]},{"raw_affiliation_string":"Heme/Onc, UC, San Diego, San Diego, CA, USA","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112235396","display_name":"John D. McMannis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John McMannis","raw_affiliation_strings":["BMT, UT/MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BMT, UT/MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078848675","display_name":"Charles E. Prussak","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"C. Prussak","raw_affiliation_strings":["MemGen, LLC, Solana Beach, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MemGen, LLC, Solana Beach, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036828560","display_name":"Thomas J. Kipps","orcid":"https://orcid.org/0000-0002-0064-4549","observed_orcids":["https://orcid.org/0000-0002-0064-4549"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas J. Kipps","raw_affiliation_strings":["CLL Research Consortium, San Diego, CA, USA","Heme/Onc, UC, San Diego, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CLL Research Consortium, San Diego, CA, USA","institution_ids":[]},{"raw_affiliation_string":"Heme/Onc, UC, San Diego, San Diego, CA, USA","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5027575595","display_name":"Michael J. Keating","orcid":"https://orcid.org/0000-0002-9121-6450","observed_orcids":["https://orcid.org/0000-0002-9121-6450","https://orcid.org/0000-0002-4008-9893"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael J. Keating","raw_affiliation_strings":["CLL Research Consortium, San Diego, CA, USA","Leukemia, UT/MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CLL Research Consortium, San Diego, CA, USA","institution_ids":[]},{"raw_affiliation_string":"Leukemia, UT/MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5078848675","https://openalex.org/A5112234350"],"corresponding_institution_ids":["https://openalex.org/I36258959"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.61,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.73666327,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"108","issue":"11","first_page":"2104","last_page":"2104"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9282000064849854,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9282000064849854,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.05260000005364418,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.010599999688565731,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9890000224113464},{"id":"https://openalex.org/keywords/cd154","display_name":"CD154","score":0.8349999785423279},{"id":"https://openalex.org/keywords/cd40","display_name":"CD40","score":0.7300000190734863},{"id":"https://openalex.org/keywords/gene-therapy","display_name":"gene therapy","score":0.8769999742507935},{"id":"https://openalex.org/keywords/autologous-cell-therapy","display_name":"autologous cell therapy","score":0.5640000104904175},{"id":"https://openalex.org/keywords/therapeutic-vaccines","display_name":"therapeutic vaccines","score":0.6129999756813049},{"id":"https://openalex.org/keywords/adenovirus-vectors","display_name":"adenoviral vector","score":0.6710000038146973},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.32199999690055847},{"id":"https://openalex.org/keywords/fas","display_name":"Fas","score":0.49399998784065247},{"id":"https://openalex.org/keywords/cd80","display_name":"CD80","score":0.41600000858306885},{"id":"https://openalex.org/keywords/cd86","display_name":"CD86","score":0.9440000057220459},{"id":"https://openalex.org/keywords/icam-1","display_name":"ICAM-1","score":0.7760000228881836},{"id":"https://openalex.org/keywords/cd38","display_name":"CD38","score":0.5920000076293945}],"concepts":[{"id":"https://openalex.org/C2779234475","wikidata":"https://www.wikidata.org/wiki/Q14897851","display_name":"CD154","level":5,"score":0.6387153267860413},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.6237025856971741},{"id":"https://openalex.org/C39347974","wikidata":"https://www.wikidata.org/wiki/Q21135811","display_name":"CD40","level":4,"score":0.6147472858428955},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.5768027305603027},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5017292499542236},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.47453773021698},{"id":"https://openalex.org/C2778297628","wikidata":"https://www.wikidata.org/wiki/Q5009843","display_name":"CD80","level":5,"score":0.46601393818855286},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4270875155925751},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4174477458000183},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.34535059332847595},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.2470100224018097},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v108.11.2104.2104","doi":"https://doi.org/10.1182/blood.v108.11.2104.2104","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v108.11.2104.2104","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2486093233","https://openalex.org/W899734449","https://openalex.org/W2108278854","https://openalex.org/W2128631852","https://openalex.org/W2570997432","https://openalex.org/W2097729403","https://openalex.org/W2049547199","https://openalex.org/W2343969206","https://openalex.org/W2560160217","https://openalex.org/W2057027940"],"abstract_inverted_index":{"Abstract":[0],"Chronic":[1],"lymphocytic":[2],"leukemia":[3,89,129,159,225,383,406],"(CLL)":[4],"is":[5,373,437],"a":[6,187,194,209,215],"malignancy":[7],"ideally":[8],"suited":[9],"for":[10,27,156],"therapeutic":[11],"vaccines.":[12],"CLL":[13,32,73,113,123,203,252,260,272,305,401],"B":[14,204],"cells,":[15,402],"readily":[16],"available":[17],"from":[18,385],"blood,":[19],"express":[20,44,77,310],"surface":[21],"antigens":[22],"that":[23,200],"can":[24,34],"be":[25,35,424],"targeted":[26],"immune-recognition.":[28],"Although":[29],"usually":[30],"stealth-like,":[31],"cells":[33,62,74,114,160,170,226,238,253,261,273,300,306,320,384,407],"stimulated":[36],"through":[37],"ligation":[38],"of":[39,111,121,137,158,168,218,277,298,324,396],"CD40":[40,109],"by":[41,161],"CD154,":[42],"to":[43,59,76,134,227,309,388],"immune":[45,163],"co-stimulatory":[46],"molecules,":[47],"such":[48,147],"as":[49,148],"CD80,":[50],"CD86,":[51],"and":[52,83,91,142,144,230,240,257,265,284,294,296,342,370,376,378,389,398,429,431],"adhesion":[53],"molecules":[54],"(e.g.":[55,139],"CD54),":[56],"allowing":[57,155],"them":[58],"stimulate":[60],"T":[61,100],"against":[63],"leukemia-associated":[64],"antigens.":[65],"A":[66],"phase":[67,210],"I":[68,211],"clinical":[69,84,212],"trial":[70,213],"with":[71,86,96,183,214,254,262,274,411],"autologous":[72,224],"transduced":[75,169,299,420],"murine":[78],"CD154":[79,178,198],"previously":[80,282],"demonstrated":[81,393],"tolerability":[82,229],"activity":[85],"reduction":[87],"in":[88,98,128,180,312,365,408],"counts":[90,102,130],"lymph":[92],"node":[93],"size":[94],"associated":[95],"increases":[97],"leukemia-specific":[99],"cell":[101,361],"(Blood":[103],"96:2917Blood":[104],"96:2000).":[105],"In":[106],"vivo":[107],"bystander":[108],"stimulation":[110],"non-transduced":[112],"also":[115],"was":[116,171,191,290,301],"noted":[117,357],"following":[118,351],"intravenous":[119],"administration":[120],"CD154-transduced":[122],"cells.":[124,205],"The":[125,303],"acute":[126],"decreases":[127],"were":[131,281,286,307,356,367],"possibly":[132],"due":[133],"induced":[135,308,394],"expression":[136,276,395],"death-receptors":[138],"CD95":[140,311,397],"(Fas)":[141],"DR5)":[143],"pro-apoptotic":[145],"proteins":[146],"the":[149,322,359,405,409],"BH3-":[150],"interacting-domain":[151],"death":[152],"agonist":[153],"(Bid),":[154],"clearance":[157],"innate":[162],"effector":[164],"mechanisms.":[165],"Repeated":[166],"dosing":[167],"initiated;":[172],"however,":[173],"some":[174,181],"patients":[175,235,250,270,280,316,335,422],"developed":[176],"anti-murine":[177],"antibodies,":[179],"cases":[182],"neutralizing":[184],"activity.":[185,231],"Therefore,":[186],"new":[188],"replication-defective":[189],"adenovirus":[190],"constructed":[192],"encoding":[193],"humanized,":[195],"functional,":[196],"membrane-stable":[197],"(ISF35)":[199],"efficiently":[201],"transduces":[202],"We":[206],"are":[207],"conducting":[208],"single":[216],"dose":[217],"1x108,":[219],"3x108,":[220],"or":[221],"1x109":[222],"ISF35-transduced":[223,304,319],"assess":[228],"To":[232],"date,":[233],"4":[234,415],"have":[236,328],"had":[237,251,259,271],"collected":[239],"transduced.":[241],"Patient":[242,414],"characteristics:":[243],"Rai":[244],"I=2,":[245],"III=1,":[246],"IV=1;":[247],"ALC=21\u2212135K/\u03bcL;":[248],"2":[249,279,285,426],"17p":[255,412],"del,":[256],"another":[258],"trisomy":[263],"12":[264],"complex":[266],"cytogenetic":[267],"abnormalities;":[268],"3":[269,334],"high-level":[275],"CD38;":[278],"treated":[283,425],"treatment-naive.":[287],"Transduction":[288],"efficiency":[289],"49,":[291],"77,":[292],"53,":[293],"57%,":[295],"viability":[297],"92\u201395%.":[302],"all":[313],"cases.":[314],"Three":[315],"received":[317],"their":[318],"at":[321,358],"time":[323],"abstract":[325],"submission.":[326],"There":[327],"been":[329],"no":[330,353],"infusion-related":[331],"toxicities.":[332],"All":[333],"experienced":[336],"fever":[337],"(Grade":[338,344],"less":[339,345],"than":[340,346],"2)":[341,347],"fatigue":[343],"lasting":[348],"1\u20134":[349],"days":[350],"treatment;":[352],"dose-limiting":[354],"toxicities":[355],"1x108":[360],"dose.":[362],"Acute":[363],"reductions":[364],"ALC":[366],"36,":[368],"64,":[369],"0%,":[371],"follow-up":[372],"4,":[374],"2,":[375],"<1wk":[377],"continues.":[379],"Preliminary":[380],"data":[381],"on":[382,400,404],"blood":[386],"prior":[387],"48":[390],"hr":[391],"post-infusion":[392],"DR5":[399],"including":[403],"patient":[410],"del.":[413],"will":[416,433],"receive":[417],"3x108":[418],"ISF35":[419],"cells;":[421],"must":[423],"wks":[427],"apart;":[428],"enrollment":[430],"treatment":[432],"continue":[434],"unless":[435],"DLT":[436],"observed.":[438]},"counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2017-01-06T00:00:00"}